Variant report
Variant | nsv882459 |
---|---|
Chromosome Location | chr5:99611807-99696831 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs949677 | chr5:99611807-99611808 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs369016355 | chr5:99611848-99611849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565541264 | chr5:99611853-99611854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532181917 | chr5:99611912-99611913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550570467 | chr5:99611928-99611929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569016582 | chr5:99611962-99611963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536342009 | chr5:99612004-99612005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142801912 | chr5:99612017-99612018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548226593 | chr5:99612037-99612038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566552080 | chr5:99612038-99612039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146583719 | chr5:99612053-99612054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558593181 | chr5:99612069-99612070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1904145 | chr5:99612096-99612097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542457089 | chr5:99612132-99612133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75272760 | chr5:99612139-99612140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191077722 | chr5:99612186-99612187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556927839 | chr5:99612277-99612278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182863554 | chr5:99612282-99612283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372801237 | chr5:99612302-99612303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186007491 | chr5:99612305-99612306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116093654 | chr5:99612328-99612329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527833506 | chr5:99612347-99612348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573375686 | chr5:99612369-99612370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540808744 | chr5:99612390-99612391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376090640 | chr5:99612391-99612392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190032644 | chr5:99612400-99612401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73151542 | chr5:99612431-99612432 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs114412187 | chr5:99612438-99612439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544263856 | chr5:99612441-99612442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139128881 | chr5:99612567-99612568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529666195 | chr5:99612655-99612656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28377972 | chr5:99612671-99612672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2546170 | chr5:99612695-99612696 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs149933138 | chr5:99612753-99612754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145089897 | chr5:99612782-99612783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552346451 | chr5:99612801-99612802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs324881 | chr5:99612805-99612806 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs565117074 | chr5:99612852-99612853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555995309 | chr5:99612920-99612921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187452218 | chr5:99612926-99612927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538058512 | chr5:99612973-99612974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536616382 | chr5:99612981-99612982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527710715 | chr5:99612985-99612986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192714644 | chr5:99612991-99612992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554802333 | chr5:99613006-99613007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573268904 | chr5:99613023-99613024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149122916 | chr5:99613031-99613032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182749618 | chr5:99613043-99613044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2617323 | chr5:99613069-99613070 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs2617322 | chr5:99613108-99613109 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99611400-99612400 | Weak transcription | Fetal Brain Male | brain |
2 | chr5:99612400-99613200 | Enhancers | Fetal Brain Male | brain |
3 | chr5:99612600-99613200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr5:99634400-99634800 | Enhancers | Dnd41 | blood |
5 | chr5:99634400-99634800 | Enhancers | HMEC | breast |
6 | chr5:99634400-99636200 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr5:99634600-99635000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr5:99634600-99635000 | Enhancers | NHEK | skin |
9 | chr5:99634600-99635600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr5:99637400-99637600 | Enhancers | Brain Germinal Matrix | brain |
11 | chr5:99637600-99638200 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr5:99638200-99639000 | Enhancers | Brain Germinal Matrix | brain |
13 | chr5:99639000-99639400 | Weak transcription | Brain Germinal Matrix | brain |
14 | chr5:99639400-99640800 | Enhancers | Brain Germinal Matrix | brain |
15 | chr5:99641400-99642400 | Enhancers | HUVEC | blood vessel |
16 | chr5:99641600-99642200 | Enhancers | NHEK | skin |
17 | chr5:99641800-99642200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr5:99649000-99649800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr5:99649200-99649800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
20 | chr5:99649200-99650000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
21 | chr5:99649200-99650000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr5:99687600-99688000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr5:99696400-99696600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |